Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation
Multiple Sclerosis Journal · 2025-10 · 31 (12) · 1401-1416
DOI: 10.1177/13524585251349129 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Multiple Sclerosis Journal, online erschienen am 07.07.2025. Verfasst von Giacomo Boffa und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 113 Literaturangaben.
Abstract (Originalsprache)
Multiple sclerosis (MS) presents a spectrum of disease activities, making prognostication and treatment challenging. Our focus on aggressive MS (AMS), a subset lacking a universally accepted definition, aims to clarify its identification and management. Here we critically dissect the different criteria for defining AMS based on the latest research and consensus, the early prognostic factors which can unambiguously identify aggressive variants early in the disease course and the available high-efficacy therapies, with a special focus on autologous haematopoietic stem cell transplantation (AHSCT), which is considered a standard of care for relapsing-remitting MS refractory to disease-modifying treatments. The review explores the potential of tailoring AHSCT protocols to individual risk and disease activity profiles, suggesting a personalized approach that could optimize treatment efficacy and safety. While awaiting the results of ongoing randomized clinical trials, AHSCT should be considered for patients with poor prognostic factors early in the disease course, in case of suboptimal response to disease-modifying therapies, but also in naïve patients with AMS experiencing rapid disability accrual.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
- IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
- Department of Neurology, IRCCS San Raffaele Hospital, Milan, Italy.
- Vita-Salute San Raffaele University, Milan, Italy.
- Department of Neurosciences, Drug and Child Health, University of Florence, Florence, Italy.
- Tuscan Region Multiple Sclerosis Referral Centre, Careggi University Hospital, Florence, Italy.
ORCID-Profile: Giacomo Boffa, Angela Genchi, Alice Mariottini, Elisa Roldan Galvan, Lucia Moiola
Zitieren
APA
Boffa, G., Genchi, A., Mariottini, A., Brittain, G., Snowden, J., Alexander, T., Badoglio, M., Roldan Galvan, E., Muraro, P. A., Sharrack, B., Saccardi, R., Inglese, M., Moiola, L., & Greco, R. (2025). Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation. Multiple Sclerosis Journal, 31(12), 1401-1416. https://doi.org/10.1177/13524585251349129
Vancouver
Boffa G, Genchi A, Mariottini A, Brittain G, Snowden J, Alexander T, et al. Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation. Multiple Sclerosis Journal. 2025;31(12):1401-1416. doi:10.1177/13524585251349129
BibTeX
@article{Boffa2025,
author = {Boffa, Giacomo and Genchi, Angela and Mariottini, Alice and Brittain, Gavin and Snowden, John and Alexander, Tobias and Badoglio, Manuela and Roldan Galvan, Elisa and Muraro, Paolo A and Sharrack, Basil and Saccardi, Riccardo and Inglese, Matilde and Moiola, Lucia and Greco, Raffaella},
title = {Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation},
journal = {Multiple Sclerosis Journal},
year = {2025},
volume = {31},
number = {12},
pages = {1401--1416},
doi = {10.1177/13524585251349129}
}
EUVIMED